Cargando…
Trisenox disrupts MDM2-DAXX-HAUSP complex and activates p53, cell cycle regulation and apoptosis in acute leukemia cells
Trisenox (TX) has been used in the treatment of both de novo and relapsed acute promyelocytic leukemia (APL) patients. Using in vitro APL cell lines model in this research, we report on a new target of TX action through disruption of MDM2-DAXX-HAUSP complex, degradation of MDM2, and activation of p5...
Autores principales: | Kumar, Sanjay, Brown, Andrea, Tchounwou, Paul B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145703/ https://www.ncbi.nlm.nih.gov/pubmed/30237857 http://dx.doi.org/10.18632/oncotarget.26025 |
Ejemplares similares
-
Trisenox Disrupts MDM2-DAXX-HAUSP Complex and Induces Apoptosis in a Mouse Model of Acute Leukemia
por: Kumar, Sanjay, et al.
Publicado: (2020) -
HAUSP-nucleolin interaction is regulated by p53-Mdm2 complex in response to DNA damage response
por: Lim, Key-Hwan, et al.
Publicado: (2015) -
Structural Basis of Competitive Recognition of p53 and MDM2 by HAUSP/USP7: Implications for the Regulation of the p53–MDM2 Pathway
por: Hu, Min, et al.
Publicado: (2006) -
HAUSP, a novel deubiquitinase for Rb – MDM2 the critical regulator
por: Bhattacharya, Seemana, et al.
Publicado: (2014) -
DNA Damage, Cell Cycle Arrest, and Apoptosis Induction Caused by Lead in Human Leukemia Cells
por: Yedjou, Clement G., et al.
Publicado: (2015)